418317

SITAGLIPTIN MITIGATES SCOPOLAMINE-INDUCED NEUROCOGNITIVE DEFICITS VIA ACTIVATION OF Nrf2/HO-1 PATHWAY AND IMPROVED MITOCHONDRIAL ACTIVITY

Article

Last updated: 29 Mar 2025